Preventing Cancer Metastasis by Targeting the Epithelial-to-Mesenchymal Transition
CSEF · 2013 Biochemistry/ Molecular Biology
Overview
Objectives/Goals The goal of this study is to establish a model system for screening potential compounds that can selectively inhibit cancer stem cells (CSCs), using the mesenchymal cells generated by an established method of inducing epithelial-to-mesenchymal transition (EMT) in cell lines in vitro. Methods/Materials Cell lines H358 (lung cancer) and LIM 1863 (colon cancer) were treated with cytokines TNF-=CE=B1 and TGF-=C3=9F for 3 days; and the analytical procedures such as phase contrast and fluorescent microscopy, Western Blot, Taqman qPCR, Immunocytochemistry, and cell proliferation assay were used to quantitatively assess the molecular and phenotypic change that occurred within the cells to verify that they underwent EMT. Mesenchymal and epithelial H358 cells were then treated with Salinomycin, using a pan-cytotoxic compound- Staurosporine as comparison, and the data collected was analyzed using IC50 graphs as well as a pair-wise student t-test to assess selectivity of the hypothesized CSC inhibitor, Salinomycin. Results After treatment with the cytokines for 3 days, the cells acquired morphological characteristics such as elongation and dissemination out of colonies, as well as a many fold increase in mesenchymal markers and no change in the epithelial marker for RNA expression, an increase in mesenchymal markers and a decrease in the epithelial marker for protein expression, and a greater than 50% decrease in proliferation. After treatment with the two drugs, the mesenchymal cells were inhibited at the same rate as the epithelial cells by salinomycin at roughly a 10 fold lower concentration, while there was no statistically significant difference for inhibition of the two cell types by staurosporine. Conclusions/Discussion In this study, it was demonstrated that cancer cells can be induced to pass through EMT by treatment with cytokines. The induced mesenchymal cells have reduced proliferation rate, increased expression of mesenchymal markers, and increased resistance to cytotoxic compounds, and are extremely similar to CSCs. However, they became more sensitive to salinomycin. The model systems established in this study can potentially be used to screen for small molecule compounds or biological agents that target EMT and cancer stem cells.
Summary statement
A model system was established and validated for discovery of medicines specific for cancer stem cells to prevent metastasis
Help received
Used lab facility at UCSD under the supervision of Ping Jiang sponsored by Dr. Kun-Liang Guan
Competition history
- CSEF 2013
Resources
Related projects
CSEF · 2010
Sensitization of CD44+ Cancer Stem Cell Apoptosis by Sequential Inhibition of the S-Phase
CSEF · 2012
A Novel Configuration of Carbon Nanotubes to Selectively Target Chemotherapy-Resistant Cancer Stem Cells
ISEF · 2015
Advancing the Cancer Stem Cell Approach for Early Tumorigenesis: Delineation of p53 Pathways in Differentially Expressed Tumor-Initiating Cells
CSEF · 2013
The Effect of Cancer Stem Cells and the Tumor Microenvironment on Tumor Growth and Invasion
ISEF · 2022
The Evasion of Cell Death by Cancer Cells Detached From the Extracellular Matrix
CSEF · 2013
Effects of Tumor Microenvironment and Anticancer Agents on Colon Cancer
AJAS · 2020
Multi-Parameter Optimization of the ECM: A Novel Approach to Controlling Cancer
ISEF · 2015
Identification and Characterization of a Rare Subpopulation with Cancer Stem Cell Properties in Lung Cancer
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects